304 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
EMERGENT BIOSOLUTIONS INC.
AMENDED AND RESTATED STOCK INCENTIVE PLAN
1. Purpose
The purpose of this Amended and Restated Stock Incentive Plan
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
) for the purpose of calculating Adjusted Net Income (Loss) per Diluted Share. Management uses Adjusted Net Income (Loss) per Diluted Share to assess total Company
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
doses annually. C.2. Purpose The purpose of this project is to maintain the ability to manufacture and deliver licensed ACAM2000, Smallpox (Vaccinia … and will be quarantined by SNS. The lots will not be distributed by ASPR for any purpose (vaccination, research, etc.) except under an approved appropriate
8-K
EX-10.1
rlr 8fzam
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.2
wrjsifbpgzx1
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
hy74hswfe37zmy 4kic4
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
gjqkxn
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
S-8 POS
1g8bkot y9qw
12 Dec 23
Registration of securities for employees (post-effective amendment)
7:05pm
S-8
4xsf2s
11 Dec 23
Registration of securities for employees
5:22pm
S-8
vjwhtwi b20n5
11 Dec 23
Registration of securities for employees
5:22pm
8-K
EX-10.1
kl2tmwzibmah exuje
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am